Xingwei Luo1, Samuel F Law2, Xiang Wang1, Jingzheng Shi3, Wu Zeng4, Xiaoqian Ma1, Wendy Chow2, Shiyan Liu1, Wei Zhao1, Xiaoli Liu3, Shuqiao Yao1, Michael R Phillips5. 1. Medical Psychological Center, The Second Xiangya Hospital, Central South University,Changsha, Hunan 410011,China. 2. Department of Psychiatry,University of Toronto,Toronto, Ontario,Canada. 3. Xiangya School of Public Health, Central South University,Changsha, Hunan410078,China. 4. Brandeis University,Waltham MA, 02454,USA. 5. Suicide Research and Prevention Center, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine,Shanghai,China.
Abstract
BACKGROUND:Assertive Community Treatment (ACT) is an evidence-based treatment program for people with severe mental illness developed in high-income countries. We report the first randomized controlled trial of ACT in mainland China. METHODS:Sixty outpatients with schizophrenia with severe functional impairments or frequent hospitalizations were randomly assigned to ACT (n = 30) or standard community treatment (n = 30). The severity of symptoms and level of social functioning were assessed at baseline and every 3 months during the 1-year study. The primary outcome was the duration of hospital readmission. Secondary outcomes included a pre-post change in symptom severity, the rates of symptom relapse and gainful employment, social and occupational functioning, and quality of life of family caregivers. RESULTS: Based on a modified intention-to-treat analysis, the outcomes for ACT were significantly better than those of standard community treatment. ACT patients were less likely to be readmitted [3.3% (1/30) v. 25.0% (7/28), Fisher's exact test p = 0.023], had a shorter mean readmission time [2.4 (13.3) v. 30.7 (66.9) days], were less likely to relapse [6.7% (2/30) v. 28.6% (8/28), Fisher's exact test p = 0.038], and had shorter mean time in relapse [3.5 (14.6) v. 34.4 (70.6) days]. The ACT group also had significantly longer times re-employed and greater symptomatic improvement and their caregivers experienced a greater improvement in their quality of life. CONCLUSION: Our results show that culturally adapted ACT is both feasible and effective for individuals with severe schizophrenia in urban China. Replication studies with larger samples and longer duration of follow up are warranted.
RCT Entities:
BACKGROUND: Assertive Community Treatment (ACT) is an evidence-based treatment program for people with severe mental illness developed in high-income countries. We report the first randomized controlled trial of ACT in mainland China. METHODS: Sixty outpatients with schizophrenia with severe functional impairments or frequent hospitalizations were randomly assigned to ACT (n = 30) or standard community treatment (n = 30). The severity of symptoms and level of social functioning were assessed at baseline and every 3 months during the 1-year study. The primary outcome was the duration of hospital readmission. Secondary outcomes included a pre-post change in symptom severity, the rates of symptom relapse and gainful employment, social and occupational functioning, and quality of life of family caregivers. RESULTS: Based on a modified intention-to-treat analysis, the outcomes for ACT were significantly better than those of standard community treatment. ACT patients were less likely to be readmitted [3.3% (1/30) v. 25.0% (7/28), Fisher's exact test p = 0.023], had a shorter mean readmission time [2.4 (13.3) v. 30.7 (66.9) days], were less likely to relapse [6.7% (2/30) v. 28.6% (8/28), Fisher's exact test p = 0.038], and had shorter mean time in relapse [3.5 (14.6) v. 34.4 (70.6) days]. The ACT group also had significantly longer times re-employed and greater symptomatic improvement and their caregivers experienced a greater improvement in their quality of life. CONCLUSION: Our results show that culturally adapted ACT is both feasible and effective for individuals with severe schizophrenia in urban China. Replication studies with larger samples and longer duration of follow up are warranted.
Entities:
Keywords:
Assertive Community Treatment (ACT); community mental health services; family psychoeducation; randomized controlled trial (RCT); schizophrenia
Authors: Kunigunde Pausch; Katrin Blanke; Verena Niederberger; Sarah Egli; Michael Rufer; Vladeta Ajdacic-Gross; Sebastian Olbrich; Mario Müller Journal: Neuropsychiatr Date: 2022-04-15
Authors: Laura Asher; Rahel Birhane; Helen A Weiss; Girmay Medhin; Medhin Selamu; Vikram Patel; Mary De Silva; Charlotte Hanlon; Abebaw Fekadu Journal: Lancet Glob Health Date: 2022-04 Impact factor: 38.927
Authors: Ling Wang; Xi-Wang Fan; Xu-Dong Zhao; Bing-Gen Zhu; Hong-Yun Qin Journal: Int J Environ Res Public Health Date: 2020-04-05 Impact factor: 3.390